Clarity Medical (HKG:1406) expects a pre-tax loss of between approximately HK$79 million and HK$82 million for the year ended March 31, wider than the HK$2.9 million loss recorded in fiscal 2023, a Friday filing on the Hong Kong bourse said.
The ophthalmic care provider attributed the rise in loss mainly to a lower revenue; impairment loss on non-financial assets; depreciation of right-of-use assets and property, plant, and equipment; and higher consultancy fee, employee benefit, and other expenses.
Shares of the company closed nearly 2% lower on Friday.
Price (HKD): $0.52, Change: $-0.01, Percent Change: -1.89%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments